5 Current ICON Clinical Trials

ICON Clinical Trials – Overview

ICON Plc. is a global consulting agency that outsources development and commercialization services to various healthcare-related industries, including pharmaceutical companies, biotechnology companies, government and public health organizations, and medical device manufacturers.

ICON Plc. primarily focuses on providing clinical development and commercialization services to the healthcare industry.

The agency has a team of experts from across the globe with extensive experience in various therapeutic areas.

Since its inception in 1990, ICON has become one of the world’s prominent Contract Research Organizations, known for its extensive experience in clinical research.

ICON plc remains an independent CRO, now larger after its July 2021 acquisition of PRA Health Sciences (iconclinicaltrials.com). The combined company continues to offer a full range of clinical, consulting, and commercial services across all major therapeutic areas (iconplc.com). Notably, ICON has expanded its capabilities in digital and decentralized trial solutions since the merger (iconplc.com). The corporate structure remains unchanged, aside from the PRA integration—no other entity has acquired ICON, and it continues to provide comprehensive drug development and commercialization services as before.
Current ICON Clinical Trials

Let’s take a quick look at some of the existing and current clinical trials being conducted by ICON Plc.

1 – MY 3853 – 0007

Trial MY 3853 – 0007 has concluded and is no longer enrolling participants as of 2025. This study was limited to female participants (focused on a women’s health indication).

2 – GL 3507 – 0059

Trial GL 3507 – 0059 has finished (no longer recruiting as of 2025). Any previously stated eligibility criteria (age range, gender, etc.) are now moot, as the trial is no longer ongoing.

3 – AM 5480 – 0009

Trial AM 5480 – 0009 has concluded and is no longer active. All study procedures (e.g. fasting requirements, biological sample collection) have been completed as per protocol, and the originally quoted compensation is no longer applicable since the study is closed.

4 – RE 3877 – 0008

Trial RE 3877 – 0008 is no longer in progress; the study has ended and is not recruiting. There have been no further updates to eligibility or procedures, as the trial’s enrollment and conduct are complete.

5 – NO 0009 – 0537

Trial NO 0009 – 0537 has been completed and is no longer recruiting. (This trial was one of a series of studies in people with overweight/obesity, and it ran for a set duration which has now elapsed. The previously advertised compensation and contact links are now outdated, as the study is closed.

Conclusion

These are only the top ICON clinical trials currently being organized by the agency. To find out details on additional clinical trials and trials being planned for the future, visit the official ICON Plc website at https://study-volunteers.iconplc.com/study-finder/.

See Also

Patient Recruitment for Clinical Trials

SARKIS Clinical Trials

Cancer Clinical Trials